Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01988922 · ClinicalTrials.gov registry record · NA

CYP2B6 Polymorphisms in Ketamine

A NA study of Healthy Volunteers, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01988922 is a NA study of Healthy Volunteers that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01988922, a NA study of Healthy Volunteers, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.

Conditions Studied

Interventions

  • DRUG ketamine

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-11
Est. Completion 2017-05
Phase NA

What the Registry Record Tells You About NCT01988922

The ClinicalTrials.gov registry entry for NCT01988922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (94% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which ketamine is the first listed.

NCT01988922 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT01988922 about?

NCT01988922 is a clinical study titled "CYP2B6 Polymorphisms in Ketamine". This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.

What is the current status of trial NCT01988922?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-11. Estimated completion is 2017-05.

What conditions does trial NCT01988922 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT01988922?

The interventions under investigation include: ketamine (DRUG).

Who is sponsoring clinical trial NCT01988922?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01988922 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.